Bioresorbable vascular scaffold to treat in-stent restenosis: Single-center experience.

Fabien PicardRobert AvramGuillaume Marquis-GravelVictor-Xavier TadrosHung Q LyQuentin de HemptinneJean-François DorvalPhilippe L L'allierJean-François Tanguay

Published in: Journal of interventional cardiology (2017)

These real-world data using BVS in patients with ISR demonstrates that ISR treatment with ABSORB™ BVS is feasible but could have slightly higher target lesion failure rates as compared to DES. This proof of concept could be hypothesis-generating for larger randomized controlled studies.

Keyphrases

double blind
open label
electronic health record
placebo controlled
phase iii
phase ii
combination therapy
replacement therapy
smoking cessation